dabigatran has been researched along with Coronary Thrombosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eckert, R; Fleddermann, A; Hayes, C; Magalski, A; Main, ML; Muskala, P | 1 |
Goto, S; Tomita, A | 1 |
Bouvaist, H; Ennezat, PV; Gagliardi, L; Guerbaai, RA; Marlière, S | 1 |
Ahmed, I; Voyce, SJ | 1 |
Bhatt, DL; Blatchford, J; Brueckmann, M; Cannon, CP; Ellis, SG; Ferreiros Ripoll, E; Gropper, S; Hohnloser, SH; Kimura, T; Kreuzer, J; Lip, GY; Manassie, J; Massaro, JM; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Arnaout, S; Musallam, KM; Rabah, A; Sawaya, FJ; Sawaya, J | 1 |
de Maat, MP; Friedman, J; Jones, RL; Leebeek, FW; Lindeboom, W; Regar, E; Reilly, P; Smits, P; ten Berg, JM; Ulmans, VA; Verheugt, FW; Vranckx, P | 1 |
1 review(s) available for dabigatran and Coronary Thrombosis
Article | Year |
---|---|
New antithrombotics for secondary prevention of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Coronary Thrombosis; Dabigatran; Hemorrhage; Humans; Imines; Lactones; Morpholines; Platelet Activation; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Thrombin | 2014 |
2 trial(s) available for dabigatran and Coronary Thrombosis
Article | Year |
---|---|
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrilla
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Protocols; Coronary Artery Disease; Coronary Thrombosis; Dabigatran; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Research Design; Risk Factors; Stents; Stroke; Time Factors; Treatment Outcome; Warfarin | 2016 |
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients.
Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; Blood Coagulation; Coronary Artery Disease; Coronary Thrombosis; Dabigatran; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pyridines; Treatment Outcome | 2013 |
4 other study(ies) available for dabigatran and Coronary Thrombosis
Article | Year |
---|---|
Efficacy of Direct Acting Oral Anticoagulant Drugs in Treatment of Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Coronary Thrombosis; Dabigatran; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Treatment Outcome | 2019 |
Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Coronary Thrombosis; Dabigatran; Electric Countershock; Humans; Male; Radiography; Treatment Outcome | 2014 |
Primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction in a patient taking dabigatran for chronic anticoagulation.
Topics: Aged; Angioplasty, Balloon, Coronary; Antithrombins; Coronary Angiography; Coronary Occlusion; Coronary Thrombosis; Dabigatran; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Stents; Thrombectomy | 2015 |
Switching patients from warfarin to dabigatran therapy: to RE-LY or not to rely.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coronary Thrombosis; Dabigatran; Humans; Male; Recurrence; Stroke; Ultrasonography; Warfarin | 2012 |